thiazoles has been researched along with Glucose Intolerance in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (38.24) | 18.2507 |
| 2000's | 11 (32.35) | 29.6817 |
| 2010's | 10 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adil, M; Ali, MR; Bawa, S; Paudel, YN; Sharma, M | 1 |
| Ham, SA; Han, DW; Han, SG; Hur, J; Hwang, JS; Hwang, SI; Lee, CH; Lee, WJ; Paek, KS; Park, JA; Seo, HG; Shin, HC; Yoo, T | 1 |
| Gudas, LJ; Jessurun, J; Melis, M; Patel, VM; Stummer, DJ; Tang, XH; Trasino, SE | 1 |
| Dolan, H; Egan, J; Ferrucci, L; Jeffrey Metter, E; Marano, C; O'Brien, RJ; Resnick, SM; Thambisetty, M; Troncoso, JC; Wong, DF; Yang, A; Zhou, Y; Zonderman, AB | 1 |
| Abbott, MJ; Ahmadian, M; Lopes, AB; Sul, HS; Tang, T; Wang, Y | 1 |
| Barroso, E; Chacón, MR; Ferrer, L; Maymó-Masip, E; Palomer, X; Rodríguez-Rodríguez, R; Salmerón, E; Salvadó, L; Vázquez-Carrera, M; Vendrell, J; Wabistch, M; Wahli, W | 1 |
| Desai, KM; Dhar, A; Wu, L | 1 |
| Cheng, P; Di, W; Ding, G; Hu, M; Li, Y; Liu, J; Lv, S; Qi, H; Wang, L; Wu, L; Yu, J; Zha, J; Zhang, A; Zhang, X; Zhong, Y | 1 |
| Choi, J; In, J; Jeon, Y; Joo, J; Jung, H; Kang, E; Kang, J; Kim, D; Kim, Y; Lee, J; Lim, Y | 1 |
| Hanley, AJ; Harris, SB; Retnakaran, R; Ye, C; Zinman, B | 1 |
| Kazdova, L; Kren, V; Krenova, D; Seda, O | 1 |
| Yamada, N; Yatoh, S | 1 |
| Pugeat, M | 1 |
| Bandyopadhyay, G; Beeson, M; Dizon, M; Farese, RV; Gomez-Daspet, J; Grebenev, D; Kanoh, Y; Miura, A; Powe, J; Sajan, MP; Standaert, ML | 1 |
| DeFronzo, RA; He, H; Mandarino, LJ; Miyazaki, Y | 1 |
| Gaillard, T; Habash, D; Osei, K; Rhinesmith, S; Schuster, D | 1 |
| Altmann, S; Augstein, P; Berg, S; Demuth, HU; Freyse, EJ; Heinke, P; Salzsieder, E | 1 |
| Azen, S; Berkowitz, K; Buchanan, TA; Dunn, ME; Goico, J; Kjos, SL; Marroquin, A; Peters, R; Xiang, A | 1 |
| Melander, A | 1 |
| Henry, RR | 1 |
| Kawamori, R; Yoshii, H | 1 |
| Antonucci, T; Lockwood, D; McLain, R; Norris, RM; Whitcomb, R | 1 |
| Byrne, MM; Cavaghan, MK; Ehrmann, DA; Polonsky, KS | 1 |
| Linday, LA | 1 |
| Kondo, M; Yokoo, S; Yoshida, T; Yoshioka, K | 1 |
| Campbell, LK; Campbell, RK; Johnson, MD | 1 |
| Demuth, HU; McIntosh, CH; Pauly, RP; Pederson, RA; Schlenzig, D; White, HA | 1 |
| Ishii, S; King, P; Pickavance, L; Tanaka, H; Widdowson, PS; Williams, G | 1 |
| Avena, R; Curry, KM; Mitchell, ME; Nylen, ES; Sidawy, AN | 1 |
| Fujii, S; Fujita, K; Ishii, T; Kurimasa, H; Mori, T; Sato, T; Tanaka, S; Yamakita, T; Yoshioka, K | 1 |
| Azen, SP; Berkowitz, K; Buchanan, TA; Goico, J; Kjos, SL; Marroquin, A; Ochoa, C; Peters, RK; Xiang, AH | 1 |
| Ahima, RS; Bailey, ST; Banerjee, RR; Bhat, S; Brown, EJ; Lazar, MA; Patel, HR; Steppan, CM; Wright, CM | 1 |
| Funahashi, T; Hotta, K; Ishikawa, K; Kawamoto, T; Kihara, S; Kishino, BI; Kuriyama, H; Matsuzawa, Y; Mineo, I; Nakagawa, C; Nakamura, T; Nishida, M; Nishida, Y; Nishimura, T; Ohuchi, N; Takahashi, M; Tarui, S; Tokunaga, K; Watanabe, F; Yamashita, S | 1 |
| Smith, U | 1 |
7 review(s) available for thiazoles and Glucose Intolerance
| Article | Year |
|---|---|
Insulin sensitizers and atherosclerosis.
Topics: Animals; Arteriosclerosis; Glucose Intolerance; Humans; Insulin; Insulin Resistance; Receptors, Cytoplasmic and Nuclear; Thiazoles; Transcription Factors | 2002 |
[Treatment of PCOS without IVF: weight loss, insulin-sensitizing agents].
Topics: Acarbose; Chromans; Enzyme Inhibitors; Female; Glucose Intolerance; Glucosidases; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Metformin; Polycystic Ovary Syndrome; Thiazoles; Thiazolidinediones; Troglitazone; Weight Loss | 2003 |
Oral antidiabetic drugs: an overview.
Topics: Biguanides; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Glucose Intolerance; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Sulfonylurea Compounds; Thiazoles | 1996 |
Effects of troglitazone on insulin sensitivity.
Topics: Animals; Blood Glucose; Blood Pressure; Chromans; Diabetes Mellitus, Type 2; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Obesity; Thiazoles; Thiazolidinediones; Troglitazone | 1996 |
[Drug therapy in subjects with impaired glucose tolerance].
Topics: Acarbose; Biguanides; Chromans; Diabetes Mellitus, Type 2; Glucose Intolerance; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Insulin Resistance; Metformin; Pioglitazone; Risk Factors; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Trisaccharides; Troglitazone | 1996 |
Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
Topics: Animals; Chromans; Clinical Trials as Topic; Diabetes Mellitus; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
Impaired ('diabetic') insulin signaling and action occur in fat cells long before glucose intolerance--is insulin resistance initiated in the adipose tissue?
Topics: Adipocytes; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucose Intolerance; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Phosphoproteins; Signal Transduction; Thiazoles; Thiazolidinediones | 2002 |
10 trial(s) available for thiazoles and Glucose Intolerance
| Article | Year |
|---|---|
Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance.
Topics: Alanine Transaminase; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Fatty Liver; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Metformin; Obesity, Abdominal; Thiazoles; Waist-Hip Ratio | 2012 |
Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Exercise; Fatty Acids, Nonesterified; Female; Glucose Intolerance; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Isoenzymes; Male; Middle Aged; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Phosphatidylinositol Phosphates; Phosphoproteins; Phosphorylation; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones | 2003 |
Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients.
Topics: Biopsy; Blood Glucose; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucose Clamp Technique; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Secretion; Male; Middle Aged; Muscle, Skeletal; Phosphoproteins; Phosphorylation; Receptor, Insulin; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Tyrosine | 2003 |
The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study.
Topics: Adult; Black People; Blood Glucose; Body Constitution; Body Mass Index; C-Peptide; Chromans; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Genetic Predisposition to Disease; Glucose Intolerance; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Male; Placebos; Skinfold Thickness; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; California; Cholesterol, HDL; Cholesterol, LDL; Chromans; Diabetes Mellitus, Type 2; Diabetes, Gestational; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Female; Glucose Intolerance; Glucose Tolerance Test; Hispanic or Latino; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Placebos; Pregnancy; Risk Assessment; Risk Factors; Thiazoles; Thiazolidinediones; Tolbutamide; Triglycerides; Troglitazone | 1996 |
Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Chromans; Double-Blind Method; Ethnicity; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Middle Aged; Prospective Studies; Thiazoles; Thiazolidinediones; Time Factors; Triglycerides; Troglitazone | 1997 |
Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.
Topics: Administration, Oral; Adult; Animals; Chromans; Double-Blind Method; Female; Glucose; Glucose Intolerance; Glucose Tolerance Test; Guinea Pigs; Humans; Hypoglycemic Agents; Islets of Langerhans; Male; Middle Aged; Thiazoles; Thiazolidinediones; Treatment Outcome; Troglitazone | 1997 |
Trivalent chromium and the diabetes prevention program.
Topics: Chromans; Chromium; Clinical Protocols; Complementary Therapies; Diabetes Mellitus, Type 2; Diet; Exercise; Glucose Intolerance; Humans; Hypoglycemic Agents; Metformin; Safety; Thiazoles; Thiazolidinediones; Troglitazone | 1997 |
Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes.
Topics: Adult; Chromans; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Glucose; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Pregnancy; Risk Factors; Thiazoles; Thiazolidinediones; Tolbutamide; Troglitazone | 2000 |
Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial.
Topics: Adipose Tissue; Blood Glucose; Blood Pressure; Body Composition; Cholesterol; Chromans; Double-Blind Method; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Insulin; Male; Middle Aged; Risk Factors; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 2001 |
17 other study(ies) available for thiazoles and Glucose Intolerance
| Article | Year |
|---|---|
"2-(4-Fluorobenzamido)-4-methylthiazole-5-carboxylic acid" a novel thiazole compound, ameliorates insulin sensitivity and hyperlipidaemia in streptozotocin-induced diabetic rats: Plausible role of inflammatory and oxidative stress markers.
Topics: Animals; Benzamides; Biomarkers; Blood Glucose; Body Weight; Cytokines; Diabetes Mellitus, Experimental; Drinking; Feeding Behavior; Glucose Intolerance; Glycated Hemoglobin; Hyperlipidemias; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Kidney; Lipids; Liver; Organ Size; Oxidative Stress; Pancreas; Rats, Wistar; Streptozocin; Thiazoles; Toxicity Tests, Acute | 2017 |
Ligand-Dependent Interaction of PPARδ With T-Cell Protein Tyrosine Phosphatase 45 Enhances Insulin Signaling.
Topics: Active Transport, Cell Nucleus; Adipocytes, White; Alternative Splicing; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cells, Cultured; Glucose Intolerance; Hepatocytes; Humans; Insulin Resistance; Male; Mice, Inbred ICR; Muscle Fibers, Skeletal; Obesity; PPAR delta; Protein Multimerization; Protein Tyrosine Phosphatase, Non-Receptor Type 2; Recombinant Fusion Proteins; RNA Interference; Specific Pathogen-Free Organisms; Thiazoles | 2018 |
Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease.
Topics: Animals; Benzoates; Dietary Fats; Glucose Intolerance; Hyperglycemia; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Receptors, Retinoic Acid; Retinol-Binding Proteins, Cellular; Tetrahydronaphthalenes; Thiazoles; Triglycerides; Vitamin A | 2019 |
Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Aniline Compounds; Baltimore; Benzothiazoles; Cognition Disorders; Female; Glucose Intolerance; Humans; Insulin Resistance; Longitudinal Studies; Male; Prospective Studies; Radionuclide Imaging; Thiazoles | 2013 |
Desnutrin/ATGL activates PPARδ to promote mitochondrial function for insulin secretion in islet β cells.
Topics: Animals; Blood Glucose; Cells, Cultured; Diet, High-Fat; Fatty Acids; Glucose; Glucose Intolerance; Hyperglycemia; Insulin; Insulin Secretion; Insulin-Secreting Cells; Lipase; Lipolysis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; PPAR delta; RNA, Messenger; Thiazoles | 2013 |
PPARβ/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation.
Topics: 3T3-L1 Cells; Adipocytes; Alkaloids; Animals; CD36 Antigens; Cell Line; Cytokines; Fructose; Glucose Intolerance; Humans; Immunoblotting; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Lipoproteins, LDL; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; PPAR delta; PPAR-beta; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Thiazoles | 2015 |
Alagebrium attenuates acute methylglyoxal-induced glucose intolerance in Sprague-Dawley rats.
Topics: Adipose Tissue; Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucose; Glucose Intolerance; Glucose Transporter Type 4; Insulin; Insulin Receptor Substrate Proteins; Male; Phosphorylation; Pyruvaldehyde; Rats; Rats, Sprague-Dawley; Thiazoles; Tyrosine | 2010 |
Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipocytes; Adiponectin; Adipose Tissue; Animals; Body Weight; Dietary Fats; Disease Models, Animal; Enzyme Inhibitors; Glucose Intolerance; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Nicotinamide Phosphoribosyltransferase; Obesity; Piperazines; Sulfonamides; Thiazoles | 2011 |
Advanced glycation end products downregulate glucokinase in mice.
Topics: Animals; Down-Regulation; Glucokinase; Glucose Intolerance; Glucose Tolerance Test; Glycation End Products, Advanced; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Serum Albumin, Bovine; Sulfones; Thiazoles | 2011 |
Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain.
Topics: Adipocytes; Adipose Tissue; Administration, Oral; Animals; Body Composition; CD36 Antigens; Diet; Dietary Sucrose; Glucose Intolerance; Glucose Tolerance Test; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Male; Rats; Rats, Inbred BN; Rats, Inbred SHR; Rosiglitazone; Thiazoles; Thiazolidinediones | 2003 |
Efficacy of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide (P32/98) in fatty Zucker rats with incipient and manifest impaired glucose tolerance.
Topics: Animals; Blood Glucose; Body Weight; Dipeptidyl-Peptidase IV Inhibitors; Fatty Acids, Nonesterified; Glucose; Glucose Intolerance; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Isoleucine; Male; Models, Animal; Obesity; Rats; Rats, Zucker; Thiazoles; Time Factors; Tissue Culture Techniques; Triglycerides | 2008 |
Is troglitazone a real indication for obese subjects with impaired glucose tolerance?
Topics: Chromans; Diabetes Mellitus, Type 2; Glucose Intolerance; Humans; Hypoglycemic Agents; Obesity; Thiazoles; Thiazolidinediones; Troglitazone | 1997 |
Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide.
Topics: Administration, Oral; Animals; Blood Glucose; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Female; Glucose; Glucose Intolerance; Insulin; Isoleucine; Male; Obesity; Rats; Rats, Zucker; Reference Values; Thiazoles | 1998 |
The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment.
Topics: Age Factors; Animals; Body Weight; Diabetes Mellitus, Type 2; Drinking; Glucose; Glucose Intolerance; Hypoglycemic Agents; Male; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Time Factors | 1998 |
Insulin action enhancement normalizes brachial artery vasoactivity in patients with peripheral vascular disease and occult diabetes.
Topics: Aged; Blood Flow Velocity; Brachial Artery; Chromans; Fasting; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Peripheral Vascular Diseases; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
Troglitazone ameliorates insulin resistance in a diabetic patient with Prader-Willi syndrome.
Topics: Adolescent; Blood Glucose; Chromans; Diabetes Mellitus; Diabetes Mellitus, Type 1; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Obesity; Prader-Willi Syndrome; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
The hormone resistin links obesity to diabetes.
Topics: 3T3 Cells; Adipocytes; Amino Acid Sequence; Animals; Base Sequence; Chromosomes, Human, Pair 19; Cloning, Molecular; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet; DNA; Female; Gene Expression Regulation; Glucose Intolerance; Hormones; Hormones, Ectopic; Humans; Hypoglycemic Agents; Insulin Antagonists; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Nerve Growth Factor; Neutralization Tests; Obesity; Proteins; Resistin; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones | 2001 |